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ABSTRACT 
Background: Strict adherence of a gluten-free diet (GFD) has historically been recommended 
only for Celiac Disease (CD). However, its use has expanded to include using it as a treatment 
option for Type 1 Diabetes (T1DM) and as a weight loss diet strategy for the general population.  
Purpose: The purpose of this creative component was to conduct a literature review to determine 
to what extent the GFD benefits individuals with T1DM and impacts weight loss.  
Methods: An electronic literature search was conducted utilizing the Iowa State Online Library, 
PubMed and Google Scholar databases. Search terms used included “gluten and type 1 diabetes,” 
“gluten and weight loss,” “gluten and metabolic control,” and “nutritional adequacy of the 
GFD.” Peer-reviewed, full-text articles were included if they were published between January 
2010 and October 2019. A total of 24 primary research studies were included for review. Of 
these 24 studies, 9 addressed gluten and T1DM and 15 addressed gluten and weight loss. Content 
of the studies found were appraised and given a quality rating using the Evidence Analysis 
process to determine the validity of their methods, results and conclusions.  
Results: Of the primary studies included, 17 were rated as “positive” and 7 were rated as 
“neutral.” Current literature shows a potential beneficial relationship between adherence to a 
GFD and treatment of T1DM, especially considering the genetic link between CD and T1DM. 
The literature search revealed the research examining the GFD on weight loss in the general 
population is limited; most studies examining the impact of GFD on weight have been conducted 
among those with CD. The GFD impact on weight among the general, healthy population is 
mixed. However, it has been shown to be beneficial when an individual’s BMI starts in the 
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obese/overweight category; however, weight gain was also observed when the individual’s BMI 
started in the underweight category.  
Conclusions: The evidence regarding the utilization of the GFD for individuals genetically at risk 
for and/or diagnosed with T1DM and weight loss amongst the general healthy adult population 
was limited and therefore should be approached with caution.  
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STATEMENT OF PURPOSE 
 
Given the steady prevalence of CD and the increased popularity of the GFD, there is a 
need for a review of literature that examines the existing research regarding the effectiveness of 
the GFD for conditions other than CD. The purpose of this review of literature is to gain a 
comprehensive understanding of the role gluten potentially has with prevention and/or treatment 
of those with T1DM, a genetically at-risk population. Additionally, this review of literature will 
also examine the legitimacy of the GFD for weight loss. If there is evidence to support a 
potential benefit, the information obtained from this review of literature will help guide the 
recommendations I provide to patients for the use of the GFD.  
 
OUTLINE 
The proposed literature review will discuss:  
1. Background and significance of the GFD 
2. Relationship between gluten intake and T1DM 
a. Dietary gluten exposure interventions amongst those with T1DM 
b. Association between maternal gluten exposure during pregnancy and T1DM 
development of the offspring 
c. Association between gluten introduction during infancy and T1DM development.  
3. GFD as a weight loss/management dietary practice  
a. GFD association with:  
i. Weight management 
ii. Nutritional adequacy (e.g., vitamins, minerals) 
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METHODOLOGY 
 The research articles used for this review of literature were gathered online from the Iowa 
State University library, PubMed, and Google Scholar. Various search terms were used to locate 
peer-reviewed, full text literature in these search engines. The key search terms used included 
“gluten and type 1 diabetes,” “gluten and weight loss,” “gluten and metabolic control,” and 
“nutritional adequacy of the GFD.” The titles and abstracts of the identified articles were 
reviewed to determine relevance and pertinence to the review of literature. Randomized 
controlled trials were preferred, but were limited. Observational studies were used if the research 
pertained to GFD and T1DM or GFD and weight loss. The reference lists of included studies 
were cross-referenced to identify other potentially relevant studies. The search was restricted to 
studies published between January 2010 and October 2019. Table 1 displays the inclusion and 
exclusion search criteria.  
 
Table 1. Inclusion and Exclusion Criteria for Review of Literature 
 
 
Inclusion Criteria Exclusion Criteria 
Full-text articles Articles with only abstract available 
Peer-reviewed Secondary reports 
Primary research or meta-analysis Major conflict of interest that could promote 
bias with results 
No conflicts of interest reported Conflicts of interests stated 
Human studies Molecular or Animal studies  
Study taking place in America, Canada, 
Australia or Western Europe 
Countries other than America, Canada, 
Australia or Western Europe 
English publications Non-English publications 
Studies published between January 2010 and 
October 2019 
Studies published before January 2010 or 
after October 2019 
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 A total of 24 primary research articles were included in this review of literature. Each 
was critically appraised using the Evidence Analysis process (EAL, 2016). The “Worksheet 
Template” (Appendix A) was utilized from the Evidence Analysis Library (EAL) to gather 
methods, results and other pertinent information from each study (EAL, 2016). Once pertinent 
information was documented from each article, the literature was assessed for quality utilizing 
the EAL’s “Quality Criteria Checklist” to rate each article as “positive,” “neutral” or “negative” 
(Appendix B) (EAL, 2016). Based on the quality appraisal process, 17 studies were rated as 
“positive,” while 7 were rated as “neutral.” None of the studies meeting the inclusion criteria 
were awarded a “negative” rating. Appendix C provides detailed information on these 24 
articles.  
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LITERATURE REVIEW 
Background and Significance  
 Overview. Celiac Disease (CD) is a condition in which genetically susceptible individuals 
have an immune-mediated response to exposure of dietary gluten, causing damage to their small 
intestinal mucosa (Parzanese et al., 2017; Kelly, Bai, Liu & Leffler, 2015; Celiac Disease, 2009). 
Classic clinical presentation of CD is malabsorption, including symptoms of diarrhea, abdominal 
pain, weight loss, stunted growth, and low bone mineral density (Kelly et al., 2015). Celiac 
Disease is found more often in females than males, with a male-to-female ratio of 1:2.8 (Gujral, 
Freeman & Thomson, 2012). The current treatment for CD is a lifelong adherence to a strict 
gluten-free diet (GFD) (Parzanese et al., 2017; Kelly et al., 2015; Celiac Disease, 2009). If a 
GFD is not followed, patients are at increased risk for nutritional deficiencies, osteoporosis, non-
Hodgkin's Lymphoma and gastrointestinal malignancy (Kelly et al., 2015). CD can present any 
time after gluten is introduced in the diet, however, most individuals are diagnosed between the 
ages of six and nine years old (Diagnosis of Celiac Disease, n.d.). 
An individual is considered at risk for CD if they have a first-degree relative with CD or 
if they have other autoimmune diseases (Diagnosis of Celiac Disease, n.d.). Both of these risk 
factors are related to carrying the class II human leukocyte antigen (HLA) types DQ2 and/or 
DQ8 (Parzanese et al., 2017). Close family of those diagnosed with CD, such as parents, siblings 
or children will likely carry the HLA-DQ2 and/or HLA-DQ8 gene(s); however this does not 
guarantee CD development (Diagnosis of Celiac Disease, n.d.). While 30 - 40% of Whites carry 
this gene, the frequency of those diagnosed with CD is only at 3% (Kelly et al., 2015; Diagnosis 
of Celiac Disease, n.d.).  
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Carrying the HLA genotype also increases the individual’s risk of other autoimmune 
diseases including type 1 diabetes mellitus (T1DM), autoimmune thyroid disease, autoimmune 
liver disease, Down syndrome, Turner syndrome, Williams syndrome, and selective 
immunoglobulin A (IgA) deficiency (Diagnosis of Celiac Disease, n.d.). Of these autoimmune 
conditions, the relationship between T1DM and CD has been the most studied (Abid, McGlone, 
Cardwell, McCallion, & Carson, 2011; Antvorskov, Josefsen, Engkilde, Funda & Buschard, 
2014; Antvorskov et al., 2018; Frederiksen et al., 2013; Hakola et al., 2017; Haupt-Jorgensen, 
Holm, Josefsen & Buschard, 2018; Hummel, Pfluger, Hummel, Bonifacio & Ziegler, 2011; 
Lund-Blix et al., 2015; Sildorf, Fredheim, Svensson & Buschard, 2012; Svensson et al., 2016; 
Virtanen et al., 2010; Virtanen et al., 2011; Welander, Montgomery, Ludvigsson & Ludvigsson, 
2014). 
Screening and diagnosis. The number of individuals with CD, is likely higher than the 
numbers currently reported (Parzanese et al., 2017). The prevalence of diagnosed CD in the 
United States and around the world is around 1% or 1 in 133 people; however, over the last 50 
years, the prevalence of CD has increased slightly (Parzanese et al., 2017; Kelly et al., 2015; 
Celiac Disease, 2009). This increase is largely due to significant improvements towards 
screening methods and awareness of asymptomatic CD (Kelly et al., 2015). The current and 
historical gold standard for CD diagnosis has been an intestinal biopsy (Diagnosis of Celiac 
Disease, n.d.). However, serological testing of the Tissue Transglutaminase IgA (tTG-IgA) 
antibody was discovered in the 1980’s and has since been used as the first screening step when 
there is suspicion of CD (Kelly et al., 2015; Diagnosis of Celiac Disease, n.d.). The discovery of 
the tTG-IgA antibody screening has allowed simple testing on individuals who have a high 
genetic risk for CD and for those who could be asymptomatic (Kelly et al., 2015).  
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T1DM and CD. It is reported that 10% of all patients with T1DM also have a history of 
CD (Abid, et al., 2011; Antvorskov et al., 2014; Antvorskov et al., 2018; Frederiksen et al., 
2013; Hakola et al., 2017; Haupt-Jorgensen et al., 2018; Hummel et al., 2011; Lund-Blix et al., 
2015; Sildorf et al., 2012; Svensson et al., 2016; Virtanen et al., 2010; Virtanen et al., 2011; 
Welander et al., 2014). T1DM incidence is rising, particularly in children under the age of five 
years old (Antvorskov et al., 2014; Antvorskov et al.; 2018; Frederiksen et al., 2013; Haupt-
Jorgensen et al., 2018; Virtanen et al., 2010; Virtanen et al., 2011; Welander et al., 2014). There 
was a 2.8 % increase in T1DM diagnosis between 1990 and 1999, with the anticipation that the 
number of children diagnosed with T1DM will double between 2005 and 2020 (Haupt-Jorgensen 
et al., 2018). T1DM is a multifactorial disease, with both genetic and environmental factors 
placing an individual at risk for disease development. Potential environmental factors affecting 
disease susceptibility include stress, low vitamin D levels, enteroviruses, gut microbiota and 
intake of cereal proteins (including gluten) and cow’s milk proteins (Antvorskov et al., 2014; 
Haupt-Jorgensen et al., 2018). With the increase in T1DM incidence, more research exploring 
potential environmental factors such as infant dietary patterns, breastfeeding duration, and the 
presence and timing of enterovirus infections has been conducted (Welander et al., 2014).    
In addition to using the GFD to prevent and/or treat T1DM, it is also promoted as a 
weight loss strategy (Gaesser & Angadi, 2012; Marcason, 2011). Choung et al. (2017) reported 
between 2009 and 2014, the overall prevalence of CD in the United States remained steady; 
however the number of individuals following a GFD doubled from 0.6% of the population to 
1.2% (Choung et al., 2017). In addition, the gluten-free product market is expected to continually 
grow to a worth of $32.39 billion by 2025 with a compounded annual growth rate of 9.1% 
(Gluten-Free Products Market Size Worth $32.39 Billion by 2025, 2019). Many Americans 
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choose to follow a GFD because they believe it is healthier than a gluten-containing dietary 
pattern (Gaesser & Angadi, 2012; Marcason, 2011).  
Although many Americans perceive a GFD to be healthier, this dietary pattern is defined 
as a diet without gluten, a protein found in wheat, barley and rye (Parzanese et al., 2017). Dietary 
habits of gluten-free followers could vary greatly. Minimally processed foods such as fruits, 
vegetables, nuts, seeds, lean meats, fish and dairy are all naturally gluten-free and appear in a 
well-balanced diet. Whereas, someone could also consume an overabundance of processed foods 
high in added sugar, saturated fat and excess sodium and technically fit the gluten-free 
qualifications.   
This comprehensive review of literature critically assessed the current research to better 
understand: (1) the relationship between gluten and T1DM; (2) to what extent the GFD affects 
weight loss and maintenance; and (3) to determine if following the GFD without a medical 
indication presents any nutritional consequences. 
 
Gluten intake and T1DM 
Ten original research articles were included for analysis on the relationship between 
gluten intake and T1DM (Abid et al., 2011; Antvorskov et al., 2018; Frederiksen et al., 2013; 
Hakola et al., 2017; Hummel et al., 2011; Lund-Blix et al., 2015; Svensson et al., 2016; Virtanen 
et al., 2010; Virtanen et al., 2011; Welander et al., 2014). Of these 10 articles, 7 were 
observational cohort studies (Antvorskov et al., 2018; Frederiksen et al., 2013; Hakola et al., 
2017; Lund-Blix et al., 2015; Virtanen et al., 2010; Virtanen et al., 2011; Welander et al., 2014), 
1 was an observational case-controlled study (Svensson et al., 2016), 1 was a longitudinal study 
(Abid et al., 2011) and 1 was a randomized controlled trial (RCT) (Hummel et al., 2011). Of 
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these 10 articles, 7 received a “positive” quality rating (Antvorskov et al., 2018; Hakola et al., 
2017; Hummel et al., 2011; Lund-Blix et al., 2015; Svensson et al., 2016; Virtanen et al., 2010). 
The remaining 3 articles received a “neutral” rating and were all observational cohort studies 
(Frederiksen et al., 2013; Virtanen et al., 2011; Welander et al., 2014).  
 As previously mentioned, T1DM incidence has increased quickly, at a rate much faster 
than can be described by a genetic drift. This observed trend has led to increased research to 
focus on the environmental factors that influence T1DM onset and/or progression. From the 
literature search previously described, there were two distinct themes related to dietary gluten 
exposure and T1DM. These included prenatal exposure via maternal gluten intake during 
pregnancy (Antvorskov et al., 2018; Virtanen et al., 2010) and infant dietary intake when solids 
are introduced (Abid et al., 2011; Frederiksen et al., 2013; Hakola et al., 2017; Hummel et al., 
2011; Lund-Blix et al., 2015; Svensson et al., 2016; Virtanen et al., 2011; Welander et al., 2014).  
 The genetic link between CD and T1DM along the HLA gene has raised the interest in 
learning if adherence to the GFD could provide benefit to those at risk for T1DM. The 
relationship between GFD and T1DM has been explored amongst infants and children in the 
general population between birth and 15 years (Frederiksen et al., 2013; Hakola et al., 2017; 
Hummel et al., 2011; Lund-Blix et al., 2015; Welander et al., 2014) and children with T1DM 
(ages 1 - 17.7 years old) (Abid et al., 2011; Svensson et al., 2016). Although the results varied, 
the consensus from these 10 studies is there is no correlation between GFD and T1DM.    
Six infant studies included those at increased risk for T1DM due to having an immediate 
relative with T1DM or expression of the HLA genotype (Frederiksen et al., 2013; Hakola et al., 
2017; Hummel et al., 2011; Lund-Blix et al., 2015; Virtanen et al., 2010; Virtanen et al., 2011). 
These studies examined infant and maternal dietary intakes using self-report. The studies by 
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Virtanen et al. (2011) and Antvorskov et al. (2018) used validated food frequency questionnaires. 
Welander et al. (2014) and Hummel et al. (2011) utilized food diaries kept by parents. Welander 
et al. (2014) had parents keep intermittent food diaries, tracking only important feeding 
milestones such as the date of cessation of breastfeeding or the age at gluten introduction for the 
first year of life (researchers started with 17,055 eligible subjects, 7,206 were lost to follow-up). 
Whereas Hummel et al. (2011) requested parents keep a daily food record for the first 1.5 years 
of life (started with 150 eligible subjects, 30 were lost to follow-up). These diaries were used to 
assure adherence to the intervention or control group in the RCT (Hummel et al., 2011) and to 
document breastfeeding behaviors and gluten exposures in infancy (Welander et al., 2014).  
Finally, for the remaining four studies, parents answered various questions from researchers 
regarding infant intake (Frederiksen et al., 2013; Hakola et al., 2017; Lund-Blix et al., 2015; 
Virtanen et al., 2011). These questions were asked in-person, over the phone and in writing. 
Behavior-related questions included breastfeeding, formula feeding and solid food intake, 
including what kind and the age at introduction. Lund-Blix et al. (2015) required parents to keep 
records of breastfeeding frequency and food intake during the year of follow-up in addition to 
answering interview questions. This was done to assure all information was accounted for and 
ensured researchers would include all pertinent information in the event a parent-provided record 
contained information valuable to the study that would not otherwise be reported by answering a 
standardized question. Svensson et al. (2016) asked parents how well they thought they were 
following the GFD without any follow-up to support the reported dietary behavior. 
Breastfeeding is reported to be beneficial in delaying the development of T1DM amongst 
genetically at-risk infants (Lund-Blix et al., 2015). Given this association with breastfeeding of 
infants at high risk for T1DM, Frederiksen et al. (2013) assessed the protective factors of 
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breastfeeding while introducing gluten in an infant’s diet and found it to be protective against 
T1DM development (n=53, HR 0.47, 95% CI: 0.26-0.86, p=0.01). Neither Lund-Blix et al 
(2015) or Frederiksen et al. (2013) considered overall maternal dietary intake while 
breastfeeding, but they did control for confounding factors such as family history of T1DM, 
maternal education level and other perinatal factors such as delivery type, birth weight and 
exposure to maternal smoking during pregnancy. Gluten exposure during infancy has been 
shown not to be associated with any significant protection against islet cell autoimmunity 
progression or T1DM development (Frederiksen et al., 2013; Hakola et al., 2017; Hummel et al., 
2011; Lund-Blix et al., 2015; Virtanen et al., 2011; Welander et al., 2014). In fact, Frederiksen et 
al. (2013) and Virtanen et al. (2011) reported early food introduction, even those without gluten 
(< 4 month and > 6 months respectively), had a higher association with T1DM development (HR 
1.91, 95% CI: 1.04 – 3.51, p = 0.04 and HR 1.75, 95% CI: 1.11 – 2.75, p = 0.006, respectively). 
Both reported confounding variables including maternal education level (Frederiksen et al., 
2013; Lund-Blix et al., 2015). However, neither controlled for socioeconomic status, which may 
have impacted the dietary intakes of the mothers and infant feeding practices (Frederiksen et al., 
2013; Lund-Blix et al., 2015). In the U.S., the American Academy of Pediatrics (AAP) 
recommends exclusive breastfeeding or formula feeding until the age of 6 months (Infant Food 
and Feeding, 2019). This raises the question, were the findings reported by Frederiksen et al. 
(2013) a representation of the general introduction of foods too early or the types of food (gluten-
free or not) that lead to the findings associating with early food introduction with increased 
T1DM risk?  
Since many of these studies were observational studies, the study subjects did not receive 
any kind of training or counseling on dietary intake, with the exception of two studies. The RCT, 
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by Hummel et al. (2011) had families meet with a nutritionist to confirm understanding of a 
GFD. These study participants were given a specific timeframe in which gluten introduction was 
appropriate (6 months [control group] or 12 months [late exposure group]) (Hummel et al., 
2011). Similarly, Svensson et al., (2016) provided families with GFD dietary counseling at the 
beginning of the study, during which time they were instructed to follow the GFD if and when 
they received a T1DM diagnosis.  
Welander et al. (2014), who examined gluten introduction during infection during the 
first year of life reported that gluten introduction during the first year was not a major risk factor 
for later development of T1DM (HR 0.8, 95%CI: 0.3-1.6). However, other research has reported 
a correlation between GFD adherence and hemoglobin A1C values. Svensson et al. (2016) 
reported hemoglobin A1C values decreased 21% (p<0.001) among those newly diagnosed with 
T1DM when adhering to the GFD for 12 months. In addition, Abid et al. (2011) examined short-
term clinical and metabolic effects amongst children (ages 1.1 – 13.2 years) with confirmed both 
CD and T1DM diagnoses and found that those who adhered to a GFD had fewer severe 
hypoglycemic episodes. However, insulin needs also increased (p<0.005) (Abid et al., 2011). 
This increase in insulin requirement is noteworthy because it indicates higher blood glucose 
trends. It was not reported if these higher blood glucose values were in response to the GFD; if 
yes, it would explain the result of fewer hypoglycemic episodes. 
 This review of literature revealed mixed results between maternal gluten exposure during 
pregnancy on an infant’s T1DM risk. Virtanen et al. (2010) found correlations between gluten-
free foods consumption and increased beta cell autoimmunity in infants including low-fat 
margarines (p=0.02), berries (p=0.02), and coffee (p=0.04). These findings were only statistically 
significant, however, not clinically relevant. Virtanen et al. (2010) discussed the possibility that 
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these results could be representative of other lifestyle characteristics increasing beta cell 
autoimmunity in infants. These lifestyle factors included age, smoking habits, body mass index 
and education level of the mother, as well as, living in a rural community (Virtanen et al., 2010). 
Additionally, Antvorskov et al. (2018) reported women who consumed high gluten intakes (>20 
grams/day) during pregnancy were more likely to have offspring with T1DM (p=0.016) after 
controlling for maternal body mass index before pregnancy, family history of all diabetes 
(T1DM, T2DM, and gestational diabetes), smoking during pregnancy, parental socioeconomic 
status, delivery type and breastfeeding duration. These findings suggest that the types of foods 
consumed during pregnancy may influence T1DM diagnosis in infants who are at higher risk 
(Virtanen et al., 2010); however, is unlikely to have an impact amongst the majority of cases.   
The observational nature of the majority of the studies examining the role the GFD has 
on T1DM makes it difficult to determine exactly how much gluten exposure study participants 
had. Antvorskov et al. (2018) was the only study reviewed that attempted to measure the amount 
of gluten consumed but stated how difficult estimation of gluten exposure is to calculate. 
Additionally, the number of participants in each of these studies varied greatly, ranging from 15 
(Svensson et al., 2016) to 67,565 (Antvorskov et al., 2018). Furthermore, it is important to note 
that these studies have only reported associations, and do not reflect cause and effect. Causation 
requires manipulation of one variable and measurement of directly caused changes in the other. 
This can be observed in a controlled experiment, such as a RCT. When discussing T1DM onset 
and/or progression, it is impossible to narrow down specific variables that would cause disease 
outcomes when it is possible other factors could contribute.  Based on this review, it appears that 
gluten intake does not influence T1DM prevention or treatment amongst high risk groups.  
 
 16 
 
GFD as a Weight Loss/Management Dietary Practice  
 The growth of the gluten-free market in the grocery industry despite a stable CD 
diagnosis rate suggests consumers are interested in gluten-free products even without having a 
medical indication. Many consumers report adhering to the GFD because they believe it to be a 
healthier option (Gaesser & Angadi, 2012; Marcason, 2011). In response, research is examining 
the use of the GFD as a weight management dietary practice. Since gluten is found in wheat-
containing products another consideration in addition to its impact on weight management is to 
understand what extent does following the GFD impact the overall nutritional quality of one’s 
diet including fiber and vitamins and minerals such as b-vitamins, iron, folate, and calcium.  
Fourteen articles regarding using the GFD as a form of weight management or 
assessment of the nutritional adequacy were reviewed. Nine reviewed articles discussed gluten 
and weight management (Barone et al., 2015; Brambilla et al., 2013; Cheng, Brar, Lee & Green, 
2010; Digiacomo, Tennyson, Green & Demmer, 2013; Kabbani et al., 2012; Kim et al., 2014; 
Newnham, Shepherd, Strauss, Hosking & Gibson, 2016; Reilly et al., 2011; Ukkola et al., 2012) 
while five articles discussed the overall nutritional adequacy of the GFD (Babio et al., 2017; 
Martin, Geisel Maresch, Krieger, & Stein, 2013; Miranda, Lasa, Bustamante, Churruca & Simon, 
2014; Shepherd & Gibson, 2012; Wild, Robins, Burley, & Howdle, 2010). Seven of the gluten 
and weight management studies were rated as “positive” and consisted of cohorts and case-
controlled designs (Barone et al., 2015; Brambilla et al., 2013; Cheng et al., 2010; Kabbani et al., 
2012; Newnham et al., 2016; Reilly et al., 2011; Ukkola et al., 2012) while two (cohort design) 
were rated as “neutral” (Digiacomo et al., 2013; Kim et al., 2014). Of the five articles examining 
the nutritional adequacy of the GFD, three were awarded a “positive” rating (Babio et al., 2017; 
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Miranda et al., 2014; Shepherd & Gibson, 2012), while two were rated as “neutral” (Martin et 
al., 2013; Wild et al., 2010).  
 
GFD and Weight Management 
 The majority of the research looking at the association between the GFD and weight 
management has been primarily conducted in populations with CD, for whom the diet is 
medically indicated (Barone et al., 2015; Brambilla et al., 2013; Cheng et al., 2010; Kabbani et 
al., 2012; Newnham et al., 2016; Reilly et al., 2011; Ukkola et al., 2012). Nine studies were 
examined (Barone et al., 2015; Brambilla et al., 2013; Cheng et al., 2010; Digiacomo et al., 
2013; Kabbani et al., 2012; Kim et al., 2014; Newnham et al., 2016; Reilly et al., 2011; Ukkola 
et al., 2012). Of these, seven were conducted amongst those with CD (Barone et al., 2015; 
Brambilla et al., 2013; Cheng et al., 2010; Kabbani et al., 2012; Newnham et al., 2016; Reilly et 
al., 2011; Ukkola et al., 2012) and two were conducted with the general population who did not 
have CD (Digiacomo et al., 2013; Kim et al., 2014). The studies reviewed included all ages from 
13 months to 80 years (Barone et al., 2015; Brambilla et al., 2013; Cheng et al., 2010; 
Digiacomo et al., 2013; Kabbani et al., 2012; Kim et al., 2014; Newnham et al., 2016; Reilly et 
al., 2011; Ukkola et al., 2012). All studies utilized self-reported dietary intakes. The consensus of 
this review is that there is not enough evidence to support prescribing the GFD for weight 
management in the general, healthy population. However, following a GFD for those with CD is 
shown to be effective in helping to achieve a healthier weight either through weight loss for 
those who are overweight/obese or weight gain for those who are underweight. 
Several of the studies provided subjects with in-person consultations with dietitians or 
nutritionists to assess adherence to the GFD (Cheng et al., 2010; Kabbani et al., 2012; Reilly et 
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al., 2011; Newnham et al., 2016; Barone et al., 2016). These consultations included education for 
following the GFD (Cheng et al., 2010; Newnham et al., 2016) and assessment of diet history 
both in-person in a personal interview (Cheng et al., 2010; Kabbani et al., 2012; Newnham et al., 
2016; Reilly et al., 2011) and from a 7-day food diary (Barone et al., 2015). Cheng et al., 2010 
included nutrition counseling in their appointments and while nutrition education for weight 
management was not included in the methods, it was addressed by the dietitian. Three studies 
had participants complete a self-report question using the National Health and Nutrition 
Education Survey (NHANES) 2009-2014 survey (Digiacomo et al., 2013; Kim et al., 2014) or 
the Health Behaviour and Health among the Finnish Adult Population (Ukkola et al., 2012); no 
additional interventions or follow-up questions were conducted (Ukkola et al., 2012; Kim et al., 
2016; and Digiacomo et al., 2013).  
 Weight gain while adhering to the GFD for those with CD, from infants to adults, who 
were classified as underweight (BMI <18.5 kg/m2 in adults and BMI-for-age <5th percentile in 
children) or normal weight (BMI of 18.50-24.99 kg/m2 for adults and BMI-for-age percentile 5 – 
84% in children) prior to following the GFD was reported (Barone et al., 2015; Brambilla et al., 
2013; Cheng et al., 2010; Kabbani et al., 2012; Newnham et al., 2016; Reilly et al., 2011; Ukkola 
et al., 2012). Similarly, Kabbani et al. (2012) and Barone et al. (2016) reported adults with CD 
who followed the GFD experienced weight gain (p< 0.002), but this gain did not result in a new 
BMI classification. For this population, a significant weight gain for those classified as 
underweight or normal weight may be beneficial as malnutrition is common due to the 
malabsorption issues related to untreated CD. Contrary to these findings, several studies 
examining the relationship between the GFD and weight management for those with CD who 
were classified as overweight or obese (BMI >25.00 kg/m2 in adults and BMI-for-age >85th 
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percentile in kids) reported significant weight loss (Cheng et al., 2010; Reilly et al., 2011; 
Ukkola et al., 2012). Reilly et al. (2011) found 75% of children (ages 1 – 20 years) with 
overweight/obese BMI z-scores significantly decreased their BMI (mean change in BMI z-
score/month = -0.01, p=0.01) while on the GFD. Likewise, Cheng et al. (2010) and Ukkola et al. 
(2012) both found weight loss among the individuals classified as overweight and obese but 
these outcomes were not significant. Again, these findings suggest that for those who have 
diagnosed CD, following the GFD may help move participants toward a healthier weight range 
whether that is through weight gain or loss. Finally, a review of the NHANES 2009-2014 data 
revealed no significant relationship between following a GFD and weight classification for adults 
without CD (p=0.053) (Digiacomo et al., 2013; Kim et al., 2017).  
 Each study exploring the relationship between the GFD and weight management had 
several limitations. One limitation included the small to medium sample sizes utilized in 7 of the 
9 studies (n=78-698 subjects) (Barone et al., 2015; Brambilla et al., 2013; Cheng et al., 2010; 
Kabbani et al., 2012; Newnham et al., 2016; Reilly et al., 2011; Ukkola et al., 2012). The 
subjects recruited for these small to medium-sized samples were also individuals with CD. Both 
the sample size and lack of diversity in study subjects is a limitation because it makes it difficult 
to generalize study results to the general population without CD.  
Another limitation is the lack of dietary compliance measurement. Several studies 
reported adherence to the GFD, yet they did not use food diary, dietary recalls, food frequencies 
or other validated surveys or tools to measure intakes (Ukkola et al., 2012; Kim et al.,2016; 
Digiacomo et al., 2013). Even though the majority of the remaining studies included in this 
review utilized follow-up techniques such as dietitian/nutritionist consults and a 7-day food 
diary, all intakes were still self-reported and leave potential room for error. 
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 A final limitation is the location of the studies. Four out of nine studies took place outside 
the U.S. This is a limitation because while the studies included in this review had a dietary 
pattern similar to the United States, it is not an exact replica and results may be attributable to the 
overall dietary and activity practices of these countries and not solely related to the GFD.  The 
GFD has been shown to be helpful in achieving a healthy BMI in individuals with CD. However, 
there is not enough evidence to support the use of the GFD as a weight management tool in the 
general, non-CD population.  
 
The Nutritional Implications Related to the GFD  
When questioning if a GFD is a healthier dietary pattern compared to one that contains 
gluten, it is imperative to consider common nutritional adequacies and inadequacies of the diet. It 
is also important to consider how the dietary pattern of those following a GFD compares 
nutritionally to the average individual. This comparison between the average consumer and those 
following a GFD will help to determine recommendations for RDNs in their practice.  
Studies included in this review assessing the nutritional adequacy of the GFD considered 
primarily the adequacy of the GFD followers with CD. However, Miranda et al. (2014) also 
studied the nutrient value of alternative gluten-free products on the market. Results across the 
five studies included in this section found consistent nutritional inadequacies that are noteworthy 
for GFD followers.  
Subjects included in this nutritional adequacy analysis all had CD and ranged in ages 
from 10 to 80 years old (n=58-197 subjects). The dietary intakes of the subjects was collected via 
validated three to seven day food diaries that included weekdays and weekend days (Babio et al., 
2017; Martin et al., 2013; Miranda et al., 2014; Shepherd & Gibson, 2012; Wild et al., 2010). 
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The study by Miranda et al. (2014) used additional dietary tracking methods, including a 
validated FFQ and a 24-hour diet recall administered by a trained dietitian.  
Various electronic nutrition analysis software programs completed assessments of the 
food diaries. Each program utilized either photographic imaging to estimate portion sizing 
(Babio et al., 2017; Miranda et al., 2014; Wild et al., 2010) or required subjects to use household 
measures to record intakes (Martin et al., 2013; Shepherd & Gibson, 2012). Miranda et al. (2014) 
used nutrient information from national databases for analysis of intakes, while Babio et al. 
(2017) used nutrient information from food labels. Wild et al. (2010), Martin et al. (2013), and 
Shepherd & Gibson (2012) all used a combination of nutrient information from a national 
database including products in each respective study’s grocery market and information from food 
manufacturers for products not found in the database.  
Miranda et al. (2014) examined 206 specific gluten-free products and 289 gluten-
containing equivalent products found in the Spanish market. The gluten-free products contained 
twice as much fat (p=0.001) and one-third less protein (p<0.001) than their gluten-containing 
counterparts. This is likely to help with the palatability of the product. Gluten itself is a protein 
and contributes significantly to the texture and structure of baked goods. When gluten is 
removed often fat is used as a replacement (Miranda et al., 2014).  
  When the dietary intakes of GFD followers were evaluated several studies identified low 
consumption of several nutrients including iron, folic acid, fiber, magnesium, zinc, thiamine, and 
calcium (Babio et al., 2017; Martin et al., 2013; Miranda et al., 2014; Shepherd & Gibson, 2012; 
Wild et al., 2010). While the consumption of these nutrients were observed to be low among 
those following a GFD, these inadequacies are also common in the general population 
(Micronutrient Inadequacies in the US Population: an Overview, 2019); thus may not be 
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attributable to the adherence of the GFD. In fact, the 2015-2020 Dietary Guidelines for 
Americans identified several of these nutrients as a public health concern including dietary fiber, 
calcium, and iron (in females ages 19 – 50 years old) (Dietary Guidelines for Americans, 2015). 
The Dietary Guidelines placed an emphasis on following a balanced overall dietary pattern rather 
than focusing on one specific nutrient in the diet, such as gluten to ensure intake of the nutrients 
of concern are met. Therefore, dietitians should encourage the consumption of a complete dietary 
pattern and educate clients on alternative, gluten-free sources of the aforementioned nutrients if 
they choose to follow a GFD. 
 
Discussion/Conclusions  
This literature review identified multiple primary research studies discussing the potential 
link between the GFD and T1DM, the role of the GFD and weight management, and the impact 
of the GFD on nutritional intakes. There was not enough evidence to support using the GFD as 
part of a T1DM treatment plan to recommend its use outside of treatment for CD. Additionally, 
the evidence regarding the timing and type of gluten exposure in high-risk infants didn’t play a 
significant role in T1DM disease prevention.  
The use of the GFD for weight management for the average, healthy individual is limited. 
The studies reviewed indicated the GFD is effective in moving those with CD toward a healthier 
weight either through weight gain or weight loss; however, more research is needed examining 
its impact on weight among the general population. In terms of potential nutrient inadequacies, 
the nutrients of concerns identified among those following the GFD, is not different from those 
common among the general population. Overall, there is not enough evidence to support the use 
of the GFD outside of treatment for CD. Although individuals with CD are genetically at 
 23 
 
increased risk for T1DM, the GFD has not been shown to aid in prevention. Additionally, there 
is not strong enough evidence to support the use of the GFD as a weight loss strategy among the 
general population.  
 
  
 24 
 
REFERENCES 
EAL. https://www.andeal.org/evidence-analysis-manual. Published 2016. Accessed October 28, 
2019. 
Parzanese I, Qehajaj D, Patrinicola F, et al. Celiac disease: From pathophysiology to treatment. 
World Journal of Gastrointestinal Pathophysiology. 2017;8(2):27-38. 
doi:10.4291/wjgp.v8.i2.27. 
Kelly CP, Bai JC, Liu E, Leffler DA. Advances in Diagnosis and Management of Celiac Disease. 
Gastroenterology. 2015;148(6):1175-1186. doi:10.1053/j.gastro.2015.01.044. 
Celiac Disease. Evidence Analysis Library. 
https://www.andeal.org/topic.cfm?menu=5279&cat=2826. Published January 14, 2009. 
Accessed October 12, 2019. 
Gujral N, Freeman HJ, Thomson ABR. Celiac disease: Prevalence, diagnosis, pathogenesis and 
treatment. World Journal of Gastroenterology. 2012;18(42):6036-6059. 
doi:10.3748/wjg.v18.i42.6036. 
Diagnosis of Celiac Disease. Celiac Disease Foundation. https://celiac.org/about-celiac-
disease/screening-and-diagnosis/diagnosis/. Accessed October 12, 2019. 
Abid N, Mcglone O, Cardwell C, Mccallion W, Carson D. Clinical and metabolic effects of 
gluten free diet in children with type 1 diabetes and coeliac disease. Pediatric Diabetes. 
2011;12:322-325. doi:10.1111/j.1399-5448.2010.00700.x. 
Antvorskov JC, Josefsen K, Engkilde K, Funda DP, Buschard K. Dietary gluten and the 
development of type 1 diabetes. Diabetologia. 2014;57(9):1770-1780. 
doi:10.1007/s00125-014-3265-1. 
 25 
 
Antvorskov JC, Halldorsson TI, Josefsen K, et al. Association between maternal gluten intake 
and type 1 diabetes in offspring: national prospective cohort study in Denmark. Bmj. 
September 2018. doi:10.1136/bmj.k3547. 
Frederiksen B, Kroehl M, Lamb MM, et al. Infant Exposures and Development of Type 1 
Diabetes Mellitus. JAMA Pediatrics. 2013;167(9):808-815. 
doi:10.1001/jamapediatrics.2013.317. 
Hakola L, Takkinen H-M, Niinistö S, et al. Infant Feeding in Relation to the Risk of Advanced 
Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic 
Susceptibility: A Cohort Study. American Journal of Epidemiology. 2017;187(1):34-44. 
doi:10.1093/aje/kwx191. 
Haupt-Jorgensen M, Holm L, Josefsen K, Buschard K. Possible Prevention of Diabetes with a 
Gluten-Free Diet. Nutrients. 2018;10(11):1746-1766. doi:10.3390/nu10111746. 
Hummel S, Pfluger M, Hummel M, Bonifacio E, Ziegler A-G. Primary Dietary Intervention 
Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 
Diabetes: The BABYDIET study. Diabetes Care. 2011;34(6):1301-1305. 
doi:10.2337/dc10-2456. 
Lund-Blix NA, Stene LC, Rasmussen T, Torjesen PA, Andersen LF, Rønningen KS. Infant 
Feeding in Relation to Islet Autoimmunity and Type 1 Diabetes in Genetically 
Susceptible Children: The MIDIA Study. Diabetes Care. 2015;38(2):257-263. 
doi:10.2337/dc14-1130. 
Sildorf SM, Fredheim S, Svensson J, Buschard K. Remission without insulin therapy on gluten-
free diet in a 6-year old boy with type 1 diabetes mellitus. Bmj Case Reports. 2012. 
doi:10.1136/bcr.02.2012.5878. 
 26 
 
Svensson J, Sildorf SM, Pipper CB, et al. Potential beneficial effects of a gluten-free diet in 
newly diagnosed children with type 1 diabetes: a pilot study. SpringerPlus. 2016;5(1). 
doi:10.1186/s40064-016-2641-3. 
Virtanen SM, Uusitalo L, Kenward M, et al. Maternal food consumption during pregnancy and 
risk of advanced β-cell autoimmunity in the offspring. Pediatric Diabetes. 
2010;12(2):95-99. doi:10.1111/j.1399-5448.2010.00668.x. 
Virtanen SM, Takkinen H-M, Nevalainen J, et al. Early introduction of root vegetables in 
infancy associated with advanced ß-cell autoimmunity in young children with human 
leukocyte antigen-conferred susceptibility to Type 1 diabetes. Diabetic Medicine. 
2011;28(8):965-971. doi:10.1111/j.1464-5491.2011.03294.x. 
Welander A, Montgomery SM, Ludvigsson J, Ludvigsson JF. Infectious Disease at Gluten 
Introduction and Risk of Childhood Diabetes Mellitus. The Journal of Pediatrics. 
2014;165(2):326-331. doi:10.1016/j.jpeds.2014.04.003. 
Infant Food and Feeding. AAP.org. https://www.aap.org/en-us/advocacy-and-policy/aap-health-
initiatives/HALF-Implementation-Guide/Age-Specific-Content/Pages/Infant-Food-and-
Feeding.aspx. Published 2019. Accessed November 8, 2019. 
Gaesser GA, Angadi SS. Gluten-Free Diet: Imprudent Dietary Advice for the General 
Population? Journal of the Academy of Nutrition and Dietetics. 2012;112(9):1330-1333. 
doi:10.1016/j.jand.2012.06.009. 
Marcason W. Is There Evidence to Support the Claim that a Gluten-Free Diet Should Be Used 
for Weight Loss? Journal of the American Dietetic Association. 2011;111(11):1786. 
doi:10.1016/j.jada.2011.09.030. 
 27 
 
Choung RS, Unalp-Arida A, Ruhl CE, Brantner TL, Everhart JE, Murray JA. Less Hidden Celiac 
Disease But Increased Gluten Avoidance Without a Diagnosis in the United States. Mayo 
Clinic Proceedings. 2017;92(1):30-38. doi:10.1016/j.mayocp.2016.10.012. 
Gluten-Free Products Market Size Worth $32.39 Billion By 2025. Market Research Reports & 
Consulting. https://www.grandviewresearch.com/press-release/global-gluten-free-
products-market. Accessed October 12, 2019. 
Barone M, Valle ND, Rosania R, et al. A comparison of the nutritional status between adult 
celiac patients on a long-term, strictly gluten-free diet and healthy subjects. European 
Journal of Clinical Nutrition. 2015;70(1):23-27. doi:10.1038/ejcn.2015.114. 
Brambilla P, Picca M, Dilillo D, et al. Changes of body mass index in celiac children on a 
gluten-free diet. Nutrition, Metabolism and Cardiovascular Diseases. 2013;23(3):177-
182. doi:10.1016/j.numecd.2011.10.002. 
Cheng J, Brar PS, Lee AR, Green PHR. Body Mass Index in Celiac Disease. Journal of Clinical 
Gastroenterology. 2010;44(4):267-271. doi:10.1097/mcg.0b013e3181b7ed58. 
Digiacomo DV, Tennyson CA, Green PH, Demmer RT. Prevalence of gluten-free diet adherence 
among individuals without celiac disease in the USA: results from the Continuous 
National Health and Nutrition Examination Survey 2009–2010. Scandinavian Journal of 
Gastroenterology. 2013;48(8):921-925. doi:10.3109/00365521.2013.809598. 
Kabbani TA, Goldberg A, Kelly CP, et al. Body mass index and the risk of obesity in coeliac 
disease treated with the gluten-free diet. Alimentary Pharmacology & Therapeutics. 
2012;35(6):723-729. doi:10.1111/j.1365-2036.2012.05001.x. 
Kim H-S, Demyen MF, Mathew J, Kothari N, Feurdean M, Ahlawat SK. Obesity, Metabolic 
Syndrome, and Cardiovascular Risk in Gluten-Free Followers Without Celiac Disease in 
 28 
 
the United States: Results from the National Health and Nutrition Examination Survey 
2009–2014. Digestive Diseases and Sciences. 2017;62(9):2440-2448. 
doi:10.1007/s10620-017-4583-1. 
Newnham ED, Shepherd SJ, Strauss BJ, Hosking P, Gibson PR. Adherence to the gluten-free 
diet can achieve the therapeutic goals in almost all patients with coeliac disease: A 5-year 
longitudinal study from diagnosis. Journal of Gastroenterology and Hepatology. 
2016;31(2):342-349. doi:10.1111/jgh.13060. 
Reilly NR, Aguilar K, Hassid BG, et al. Celiac Disease in Children with Normal Weight and 
Overweight: Clinical Features and Growth Outcomes Following a Gluten-Free 
Diet. Journal of Pediatric Gastroenterology and Nutrition. 2011:528-531. 
doi:10.1097/mpg.0b013e3182276d5e. 
Ukkola A, Mäki M, Kurppa K, et al. Changes in body mass index on a gluten-free diet in coeliac 
disease: A nationwide study. European Journal of Internal Medicine. 2012;23(4):384-
388. doi:10.1016/j.ejim.2011.12.012. 
Babio N, Alcázar M, Castillejo G, et al. Patients With Celiac Disease Reported Higher 
Consumption of Added Sugar and Total Fat Than Healthy Individuals. Journal of 
Pediatric Gastroenterology and Nutrition. 2017;64(1):63-69. 
doi:10.1097/mpg.0000000000001251. 
Martin J, Geisel T, Maresch C, Krieger K, Stein J. Inadequate Nutrient Intake in Patients with 
Celiac Disease: Results from a German Dietary Survey. Digestion. 2013;87(4):240-246. 
doi:10.1159/000348850. 
 29 
 
Miranda J, Lasa A, Bustamante MA, Churruca I, Simon E. Nutritional Differences Between a 
Gluten-free Diet and a Diet Containing Equivalent Products with Gluten. Plant Foods for 
Human Nutrition. 2014;69(3):182-187. doi:10.1007/s11130-014-0429-6. 
Shepherd SJ, Gibson PR. Nutritional inadequacies of the gluten-free diet in both recently-
diagnosed and long-term patients with coeliac disease. Journal of Human Nutrition and 
Dietetics. 2012;26(4):349-358. doi:10.1111/jhn.12018. 
Wild D, Robins GG, Burley VJ, Howdle PD. Evidence of high sugar intake, and low fibre and 
mineral intake, in the gluten-free diet. Alimentary Pharmacology & Therapeutics. 
2010;32(4):573-581. doi:10.1111/j.1365-2036.2010.04386.x. 
Micronutrient Inadequacies in the US Population: an Overview. (2019, October 23). Retrieved 
from https://lpi.oregonstate.edu/mic/micronutrient-inadequacies/overview. 
Dietary Guidelines for Americans. (2015). doi: 10.1377/hpb20151214.174872 
 
 
  
 30 
 
APPENDIX A 
                                               WORKSHEET TEMPLATE 
Academy of Nutrition and Dietetics  
Evidence Analysis Library® Worksheet Template 
Citation  
Study Design  
Class  
Quality Rating + (Positive)    - (Negative)    (Neutral) (choose one):  
Research Purpose  
Inclusion Criteria  
Exclusion Criteria  
Description of Study 
Protocol 
Recruitment:   
Design:   
Blinding used (if applicable):   
Intervention (if applicable):   
Statistical Analysis:   
Data Collection 
Summary 
 
Timing of Measurements:  
Dependent Variables:  
Independent Variables:   
Control Variables:  
Description of Actual 
Data Sample 
Initial:    (____Males   ___ Females) 
Attrition (final N):   
Age:   
Ethnicity:   
Other relevant demographics:   
Anthropometrics:   
Location:   
Summary of Results 
Key Findings:       
 
Other Findings:   
Author Conclusion  
Reviewer Comments  
Funding Source  
Academy of Nutrition & Dietetics, Evidence Analysis Library/Evidence Analysis Manual 
 
 
 
 31 
 
APPENDIX B 
QUALITY CRITERIA CHECKLIST – PRIMARY 
Quality Criteria Checklist: Primary Research  
Symbols Used  
+ Positive: Indicates that the report has clearly addressed issues of inclusion/exclusion, bias, generalizability, and 
data collection and analysis. 
-- Negative: Indicates that these issues have not been adequately addressed. 
 Neutral: Indicates that the report is neither exceptionally strong nor exceptionally weak. 
Quality Criteria Checklist: Primary Research 
RELEVANCE QUESTIONS 
1. Would implementing the studied intervention or procedure (if found successful) result in 
improved outcomes for the patients/clients/population group? (NA for some Epi studies) 
Yes No Unclear N/A 
2. Did the authors study an outcome (dependent variable) or topic that the 
patients/clients/population group would care about? 
Yes No Unclear N/A 
3. Is the focus of the intervention or procedure (independent variable) or topic of study a 
common issue of concern to dietetics practice?  
Yes No Unclear N/A  
4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes No Unclear N/A 
If the answers to all of the above relevance questions are “Yes,” the report is eligible for designation with a plus (+) on 
the Evidence Quality Worksheet, depending on answers to the following validity questions. 
VALIDITY QUESTIONS 
1. Was the research question clearly stated? 
1.1 Was the specific intervention(s) or procedure (independent variable(s)) identified? 
1.2 Was the outcome(s) (dependent variable(s)) clearly indicated? 
1.3 Were the target population and setting specified? 
Yes No Unclear N/A 
2. Was the selection of study subjects/patients free from bias? 
2.1 Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, 
diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria 
critical to the study? 
2.2 Were criteria applied equally to all study groups? 
2.3 Were health, demographics, and other characteristics of subjects described? 
2.4 Were the subjects/patients a representative sample of the relevant population? 
Yes No Unclear N/A 
3. Were study groups comparable? 
3.1 Was the method of assigning subjects/patients to groups described and unbiased? 
(Method of randomization identified if RCT) 
3.2 Were distribution of disease status, prognostic factors, and other factors (e.g., 
demographics) similar across study groups at baseline? 
3.3 Were concurrent controls used? (Concurrent preferred over historical controls.) 
3.4 If cohort study or cross-sectional study, were groups comparable on important 
confounding factors and/or were preexisting differences accounted for by using 
appropriate adjustments in statistical analysis? 
Yes No Unclear N/A 
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3.5 If case control study, were potential confounding factors comparable for cases and 
controls? (If case series or trial with subjects serving as own control, this criterion is 
not applicable. Criterion may not be applicable in some cross-sectional studies.) 
3.6 If diagnostic test, was there an independent blind comparison with an appropriate 
reference standard (e.g., “gold standard”)? 
4. Was method of handling withdrawals described? 
4.1 Were follow up methods described and the same for all groups? 
4.2 Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, 
attrition rate) and/or response rate (cross-sectional studies) described for each group? 
(Follow up goal for a strong study is 80%.) 
4.3 Were all enrolled subjects/patients (in the original sample) accounted for?   
4.4 Were reasons for withdrawals similar across groups? 
4.5 If diagnostic test, was decision to perform reference test not dependent on results of 
test under study? 
Yes No Unclear N/A 
5. Was blinding used to prevent introduction of bias? 
5.1 In intervention study, were subjects, clinicians/practitioners, and investigators blinded 
to treatment group, as appropriate? 
5.2 Were data collectors blinded for outcomes assessment? (If outcome is measured 
using an objective test, such as a lab value, this criterion is assumed to be met.) 
5.3 In cohort study or cross-sectional study, were measurements of outcomes and risk 
factors blinded?  
5.4 In case control study, was case definition explicit and case ascertainment not 
influenced by exposure status? 
5.5 In diagnostic study, were test results blinded to patient history and other test results? 
Yes No Unclear N/A 
6. Were intervention/therapeutic regimens/exposure factor or procedure and any 
comparison(s) described in detail? Were intervening factors described? 
6.1 In RCT or other intervention trial, were protocols described for all regimens studied? 
6.2 n observational study, were interventions, study settings, and clinicians/provider 
described? 
6.3 Was the intensity and duration of the intervention or exposure factor sufficient to 
produce a meaningful effect? 
6.4 Was the amount of exposure and, if relevant, subject/patient compliance measured? 
6.5 Were co-interventions (e.g., ancillary treatments, other therapies) described? 
6.6 Were extra or unplanned treatments described? 
6.7 Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? 
6.8 In diagnostic study, were details of test administration and replication sufficient? 
Yes No Unclear N/A 
7. Were outcomes clearly defined and the measurements valid and reliable? 
7.1 Were primary and secondary endpoints described and relevant to the question?   
7.2 Were nutrition measures appropriate to question and outcomes of concern? 
7.3 Was the period of follow-up long enough for important outcome(s) to occur? 
7.4 Were the observations and measurements based on standard, valid, and reliable 
data collection instruments/tests/procedures? 
7.5 Was the measurement of effect at an appropriate level of precision? 
7.6 Were other factors accounted for (measured) that could affect outcomes? 
7.7 Were the measurements conducted consistently across groups? 
Yes No Unclear N/A 
8. Was the statistical analysis appropriate for the study design and type of outcome 
indicators? 
8.1 Were statistical analyses adequately described the results reported appropriately? 
8.2 Were correct statistical tests used and assumptions of test not violated? 
8.3 Were statistics reported with levels of significance and/or confidence intervals? 
Yes No Unclear N/A 
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8.4 Was “intent to treat” analysis of outcomes done (and as appropriate, was there an 
analysis of outcomes for those maximally exposed or a dose-response analysis)? 
8.5 Were adequate adjustments made for effects of confounding factors that might have 
affected the outcomes (e.g., multivariate analyses)? 
8.6 Was clinical significance as well as statistical significance reported? 
8.7 If negative findings, was a power calculation reported to address type 2 error? 
9. Are conclusions supported by results with biases and limitations taken into 
consideration? 
9.1 Is there a discussion of findings? 
9.2 Are biases and study limitations identified and discussed? 
Yes No Unclear N/A 
10. Is bias due to study’s funding or sponsorship unlikely? 
10.1 Were sources of funding and investigators’ affiliations described? 
10.2 Was there no apparent conflict of interest? 
Yes No Unclear N/A 
MINUS/NEGATIVE (-) 
If most (six or more) of the answers to the above validity questions are “No,” the report should be designated with a minus (-) 
symbol on the Evidence Worksheet. 
NEUTRAL () 
If the answers to validity criteria questions 2, 3, 6, and 7 do not indicate that the study is exceptionally strong, the report should be 
designated with a neutral () symbol on the Eviden 
 
 
ce  Worksheet. 
PLUS/POSITIVE (+) 
If most of the answers to the above validity questions are “Yes” (including criteria 2, 3, 6, 7 and at least one additional “Yes”), the 
report should be designated with a plus symbol (+) on the Evidence  Worksheet. 
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APPENDIX C 
 
OVERVIEW TABLE 
 
Author/ Year/ 
Study Design 
Purpose Population Intervention Key Outcomes Conclusions Limitations 
Primary Sources, Positive Quality Rating 
Hummel et 
al., 2011, 
randomized, 
controlled 
trial (parallel) 
To determine 
if infants with 
a high genetic 
risk for islet 
cell 
autoimmunity 
experience a 
lower risk of 
T1DM with 
delayed gluten 
introduction.  
Genetically high 
risk children in 
Germany less 
than two months 
of age, not yet 
exposed to 
dietary gluten.  
Children were randomly 
assigned into one of two 
groups – gluten 
introduction at 6 months 
(control) or 12 months 
(intervention) of age. 
Daily food diaries were 
used to assess adherence 
to intervention, measure 
dose at first gluten 
exposure and determine 
age at introduction of 
other foods.  
Three years after 
gluten exposure, 
children in the control 
and intervention 
groups had a 13% and 
12% (P=0.6) chance of 
developing islet 
autoantibodies, 
respectively.  
Delayed 
introduction of 
gluten into the diet 
of genetically high 
risk children is 
safe, but does not 
increase risk for 
islet autoimmunity.  
Randomization 
of dietary 
intervention 
was not 
blinded. Many 
of the 
participants that 
did not adhere 
to their 
intervention 
were in the 
intervention 
group.   
Svensson et 
al., 2016, 
observational 
(case-control) 
To investigate 
if a gluten-free 
diet at the time 
of T1DM 
onset will 
provide 
beneficial 
effects on 
diabetes 
outcome. 
Newly 
diagnosed 
children with 
T1DM (n=15), 2 
years of age or 
older, admitted 
to Copenhagen 
University 
Hospital, Herlev 
between March 
2012 and June 
2013.  
Children with newly 
diagnosed T1DM were 
instructed to follow a 
GFD. At 6 and 12 months 
post diagnosis, they were 
given a liquid mixed meal 
solution. Their response 
was measured to 
determine partial 
remission (PR). PR was 
defined as insulin dose-
adjusted A1c </= 9 or 
stimulated C-peptide 
>300 pmol/L 
Adherence to the GFD 
was strongest for the 
first 6 months. During 
these first 6 months, 
partial remission was 
observed in more kids 
on the GFD compared 
to the European 
cohort. A1c values 
were 21% lower 
(P<0.001) in the GFD 
cohort at 12 months of 
adherence to the diet.  
The GFD was 
associated with 
better outcomes in 
newly diagnosed 
T1DM patients 
evidenced by 
improvements of 
A1c and insulin 
dose-adjusted A1c.  
Small sample 
size, non-
randomized 
design.  
Hakola et al., 
2018, 
To study 
whether the 
Children born at 
Tampere and 
Parents completed 
questionnaires regarding 
There was no 
association found with 
There were no 
significant 
Information on 
the amount of 
 35 
 
observational 
(cohort) 
age at 
introduction of 
complementar
y food or food 
diversity along 
with 
breastfeeding 
plays a role 
with advanced 
islet 
autoimmunity 
or type 1 
diabetes.  
Oulu University 
Hospitals with 
the HLA 
genotype 
between 
September 1996 
and September 
2004.  
oral intake and 
breastfeeding duration. 
Questionnaires were 
collected from trained 
nurses at 3, 6, 12, 18, and 
24 months of age. 
Children were then 
assessed for 
autoantibodies and 
T1DM up to 15 years of 
age.  
duration of breast 
feeding, age at 
introduction of new 
foods, or food 
diversity and 
development of 
advanced islet 
autoimmunity and 
T1DM.   
relationships found 
between infant 
feeding and 
advanced islet 
autoimmunity and 
T1DM.  
food consumed 
at first exposure 
was not 
obtained.  
Virtanen et 
al., 2010, 
observational 
(cohort) 
To study the 
potential 
association 
between 
maternal 
dietary intake 
and advanced 
beta-cell 
autoimmunity 
in their 
offspring.  
Mothers of 
newborn infants 
from Finland 
recruited from 
three hospitals 
all of which 
express the 
genotype for 
T1DM, making 
them high risk. 
Dietary intake was self-
reported post-partum via 
validated food frequency 
questionnaires. T1DM-
associated antibodies in 
the children were 
measured in 3 – 12 month 
intervals. Antibodies 
measured included 
antibodies against islet 
cells (ICA), insulin, 
glutamate dehydroxylase, 
and islet antigen 2. 
Endpoint of the study was 
positive results for ICA 
plus one other antibody 
and/or diagnosis of 
T1DM. 
Maternal intake during 
pregnancy of butter, 
low-fat margarines, 
berries, and coffee 
increased association 
with beta-cell 
autoimmunity in 
offspring. These 
findings remained 
statistically significant 
when adjusted for 
confounding variables.  
Only weak 
relationships 
between maternal 
dietary intake 
during pregnancy 
and beta-cell 
autoimmunity were 
shown.  
Intake was 
reported to 
doctors and 
nurses, not a 
nutrition 
professional.  
Antvorskov et 
al., 2018, 
observational 
(cohort) 
To determine 
if maternal 
gluten intake 
during 
pregnancy is 
All women who 
were Danish and 
pregnant 
between January 
1996 to October 
Participants received a 
food frequency 
questionnaire at 25 weeks 
of pregnancy. Follow ups 
were conducted at 6 and 
Average maternal 
gluten intake was 13.0 
g/day and 0.37% 
(n=247) of offspring 
were diagnosed with 
The risk of T1DM 
development was 
positively related to 
maternal gluten 
Gluten intake is 
likely 
underestimated 
as it is added to 
items like flour, 
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related to 
T1DM 
development 
in their 
offspring.   
2002. Subjects 
had to be fluent 
in Danish. 
Women were 
allowed to enter 
the study more 
than once if 
pregnant 
multiple times 
and were 
recruited in first 
prenatal visit.   
18 months postpartum to 
collect information on 
breast-feeding. 
Additional follow-ups 
were conducted when the 
children were 7, 11, and 
14 years of age.  
T1DM. Compared to 
offspring of mothers 
with the lowest gluten 
intake/day (<7 grams), 
those from mothers 
with the highest intake 
(>20 grams) were 
twice as likely to have 
T1DM at follow-up 
(HR 2.0).  Positive 
correlation between 
maternal gluten intake 
and T1DM 
development 
(P=0.016).  
intake during 
pregnancy.  
bread and other 
foods. 
Information on 
the diet these 
mothers fed 
their infants 
once born is not 
provided and 
could have 
influenced 
results.  
Lund-Blix et 
al., 2015, 
observational 
(cohort) 
To investigate 
a potential 
relationship 
between 
breast-feeding 
duration and 
age at 
introduction of 
solid foods 
with the risk 
of islet 
autoimmunity 
and T1DM in 
a genetically 
at-risk 
population.  
Genetically at-
risk (expressing 
the HLA 
genotype) 
newborns from 
the general 
population in 
Norway born 
between 2001 
and 2007.  
Dietary intake was 
assessed via four 
questionnaires between 3 
and 12 months of age. 
Parents of participants 
also kept records of 
dietary intake to 
determine other food 
intake not included in 
questionnaires and to 
gather information on 
breastfeeding.  
Infants who were 
breastfed for 12 
months or longer had a 
lower risk of T1DM 
development (HR 
0.37). Breast-feeding 
for 12 months or 
longer was associated 
with lower risk of 
progression from islet 
autoimmunity 
progression to T1DM. 
The age at 
introduction of solid 
foods or breast-
feeding at the time of 
introduction is not 
related to a decreased 
risk of islet 
autoimmunity or 
T1DM.  
Breastfeeding for 
12 months or 
longer was shown 
to decrease the 
progression of islet 
autoimmunity to 
T1DM in 
genetically high 
risk children. There 
were no 
associations with 
T1DM 
development and 
age at introduction 
of solid foods.  
The primary 
limitation was 
the lower 
number of 
individuals 
diagnosed with 
T1DM. Only 
25 subjects of 
726 total 
developed 
T1DM. This 
could be a 
chance finding 
due to the study 
design. There 
could be 
unmeasured 
confounding 
variables 
present in these 
study results. A 
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randomized 
controlled trial 
would be ideal 
but is arguably 
unethical when 
measuring 
breast-feeding 
durations.  
Brambilla et 
al., 2011, 
observational 
(case-
controlled) 
To evaluate 
the changes in 
BMI of those 
with CD while 
on a GFD.  
Patients between 
ages 2 – 16 
years old with 
CD were 
recruited by 
their family 
pediatrician. 
Participants had 
to maintain a 
seronegativity in 
months before 
study to show 
adherence to 
GFD.   
Patients with CD were 
recruited and each 
matched to two healthy 
subjects. Random 
matching was done by 
pairing gender and age. 
Seronegativity was 
assumed to be adherence 
to GFD. Observation of 
BMI changes were made 
while adhering to GFD 
between at diagnosis and 
current evaluation. 
Observation time was 
a median of 4.4 years. 
CD patients were less 
frequently overweight 
or obese (12% vs 
23.3%, p= 0.014) and 
more frequently 
underweight (16% vs 
4.5%, p < 0.001)  
compared to their 
matched controls. In 
those with CD 
following a GFD, 
there was a decrease in 
the number of 
underweight subjects 
and a slight increase in 
the number of 
overweight subjects.  
The number of CD 
patients that are 
underweight at 
diagnosis is higher 
than that of their 
healthy peers.  
Retrospective 
design.  
Cheng et al., 
2010, 
observational 
(case-control) 
To determine 
the effect a 
GFD has on 
the BMI of 
those with 
CD.  
Adults ages 18 
years and older 
with confirmed 
CD and with 
documented 
BMI at 
diagnosis. 
Patient has to 
have met with 
Adherence to GFD was 
monitored by dietitian 
visits and any reports of 
doctor visits due to 
symptoms of non-
adherence. Patients met 
with dietitian annually 
after first year of 
diagnosis. Baseline BMI 
Females had lower 
BMI and fewer were 
overweight compared 
to national data. More 
males had a normal 
BMI and fewer were 
underweight compared 
to national data. On a 
GFD, 66% of those 
The GFD has a 
beneficial effect on 
BMI in CD 
patients. Those 
who were 
underweight, 
gained weight. 
Those who were 
Convenience 
sample.  
 38 
 
nutritionist 
within the last 6 
years.  
data was compared to 
U.S. general population 
data via NHANES III: 
from 1988 to 1994.  
underweight gained 
weight, 54% 
overweight and 47% 
obese lost weight.  
overweight, lost 
weight.  
Kabbani et 
al., 2012, 
observational 
(case-control) 
To observe 
BMI and 
weight 
changes in 
those who 
have CD and 
are following 
a GFD.  
Adults ages 18 
and above with 
confirmed CD 
and following a 
GFD. Recruited 
from Celiac 
treatment center.  
GFD adherence was 
confirmed by a dietitian. 
Baseline and follow-up 
information was 
compared to healthy 
population using National 
health Interview Survey 
(NHIS).  
15.8% of patients on 
GFD went from 
normal or low BMI 
class to an overweight 
BMI class. 22% of 
patients overweight at 
diagnosis gained 
weight. Mean BMI of 
cohort increased from 
24.0 to 24.6 
(P<0.001).  
Adherence to a 
GFD in those with 
CD caused 
individuals to gain 
weight no matter 
which starting BMI 
class they were in. 
Weight 
maintenance 
counseling is 
recommended 
when following a 
GFD.  
Retrospective 
design. 
Convenience 
sample.  
Ukkola et al., 
2012, 
observational 
(case-control) 
To evaluate 
change in 
BMI of those 
with CD after 
following one 
year of a 
GFD.  
All subjects 
were 16 years 
old with proven 
CD diagnosis. 
CD group was 
compared to 
general 
population 
recruited from a 
local referral 
center.  
Data was collected from a 
nationwide Finnish 
survey. BMI after one 
year of following the 
GFD was assessed and 
compared to that of the 
general population. 
Participants were newly 
diagnosed with CD.  
69% of underweight 
patients gained and 
18% of overweight 
and 42% of obese lost 
weight. The rest 
experienced no 
changes in BMI. 
Celiac group had more 
favorable BMI pattern 
than healthy 
population.  
BMI improved in 
patients who 
followed GFD for 
one year.  
Follow-up of 
one year is 
rather short.  
Barone et al., 
2016, 
observational 
(case-control) 
To evaluate 
the influence 
of a long-term 
GFD on the 
nutritional 
status of adult 
patients with 
CD compared 
Subjects for the 
CD group were 
recruited from a 
GI clinic in 
Italy. They had 
confirmed 
biopsy diagnosis 
of CD. Subjects 
CD group continued 
GFD. Healthy control 
group continued their 
normal diet. Height, 
weight, body composition 
and bone mineral density 
was collected. Dietary 
intake was evaluated 
82% of CD patients 
had a normal BMI or 
were overweight and 
10.3% were 
malnourished at time 
of diagnosis. After 
adherence to GFD, 
subjects with a normal 
GFD has positive 
effect on nutrition 
status of CD 
population without 
causing overweight 
or obese patients. 
Study patients 
did follow 
Mediterranean 
diet, which 
isn’t the best 
representation 
compared to 
typical western 
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to healthy 
controls. 
had been 
following a 
GFD for a 
median time of 
24 months. 
Healthy controls 
were matched 
for sex, age and 
social status. 
based on 7-day food diary 
at enrollment. Dietitian 
instructed patients on 
how to complete diary. 
BMI showed a 
significant weight gain 
(P=0.002), but did not 
cross over into the 
overweight or obese 
category. CD and 
control group had 
similar BMI, fat mass, 
and bone mineral 
density. Total calorie 
intake between two 
groups were 
comparable but 
amounts of lipids and 
fiber intake differed 
(P=0.003 and 
P<0.0001, 
respectively).  
 
diet and as it 
relates to this 
review. Small 
study 
population. 
Small number 
of underweight 
patients so 
results in this 
population may 
not be 
representative 
of all 
underweight 
patients. 
Shepherd et 
al., 2013, 
observational 
(case-control) 
To examine 
the nutritional 
adequacy of 
the GFD in 
people with 
CD. 
This study 
consisted of two 
groups of 
Australians. The 
first group was 
newly diagnosed 
CD patients 
recruited from a 
clinic. The 
second group 
was long-term 
treated CD 
patients 
recruited from 
private practice, 
public hospitals 
All patients assessed by a 
dietitian and educated on 
GFD, which was to be 
followed for life but was 
analyzed for the next 12 
months. Dietary 
adherence was assessed 
in follow up with 
dietitian. Questions were 
asked about adhering to 
GFD and utilizing 7 day 
food log. Food logs were 
also assessed using 
Foodworks analysis 
software. Blood samples 
were taken to assess 
electrolytes, renal 
Inadequate folate, 
calcium, iron and zinc 
intake occurred more 
frequently than in the 
overall Australian 
population. Thiamin 
and vitamin A were 
more common after 
GFD implementation. 
Fiber intake was 
inadequate for all 
except for diet-
experienced men. 
Thiamin, folate, 
vitamin A, 
magnesium, calcium 
and iron were 
Nutritional 
inadequacies are 
common in those 
following the GFD 
and could be 
contributed to long-
term poor food 
choices, but also 
inherent 
deficiencies due to 
following a GFD. 
Fortification of GF 
foods should be 
considered along 
with micronutrient 
supplementation. 
Behavioral 
changes can 
occur when 
documenting 
food intake – 
potential for 
undereating. 
Results could 
be difficult to 
generalize to 
other 
populations. 
For the diet-
experienced 
group, it was a 
prerequisite for 
the study to be 
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and 
advertisements. 
function, LFTs, iron 
studies, serum folate, 
vitamin B12, zinc, 
vitamin D, magnesium, 
calcium, and 
phosphorous. 
commonly low in 
women who were 
newly diagnosed and 
experienced dieters.  
following the 
diet, therefore, 
they could be a 
higher 
motivated 
population of 
CD patients. 
For the newly 
diagnosed 
group, they 
received more 
intensive 
follow up after 
diagnosis than 
they normally 
would. This 
intensive 
follow up was 
due to their 
involvement in 
the study and 
thus they all 
had excellent 
adherence to 
the new diet. 
Babio et al., 
2017, 
observational 
(case-control) 
To compare 
the food and 
nutrient intake 
of CD patients 
to nonceliac 
healthy 
controls.  
Subjects ages 10 
– 23 years old 
diagnosed with 
CD at a hospital 
in Spain and 
were adherent to 
GFD. Healthy 
patients were 
recruited in 
primary and 
secondary 
Dietitian met with cases 
and controls to gather 
background information 
and to teach them about 
using 3-day food record. 
Same dietitian analyzed 
food records when turned 
in. Photogenic analysis 
was used to estimate 
portion sizes on food 
records.  
CD group reported 
higher intake of added 
sugar (P<0.001) and 
total fat (P<0.017). 
Fiber intake was 
below recommended 
amounts for both 
groups. CD group 
showed lower intakes 
of folic acid, calcium, 
iron and magnesium. 
CD group had more 
unbalanced diet 
compared to 
control. (More 
added sugar and 
total fat, inadequate 
intake of 
micronutrients) 
Micronutrient 
levels for GF 
products were 
limited, 
therefore 
reported intakes 
are 
underestimated. 
No serological 
testing to test 
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schools and 
were matched 
via age, gender 
and BMI to CD 
patients.  
On a macronutrient 
level, the CD group 
ate lower amounts of 
starch and higher 
amounts of protein.  
serum nutrient 
levels.  
Miranda et 
al., 2014, 
observational 
(cross-
sectional) 
To analyze the 
nutritional 
difference 
between GF 
foods 
commonly 
consumed in 
Spain to their 
gluten-
containing 
equivalents. 
Also to 
analyze GFD 
of Celiac 
adults.  
Adult CD 
patients from the 
Basque Country 
in Spain.  
Analysis of nutritional 
value of GF and gluten 
containing products was 
completed based on label 
packaging. Analysis of 
subject intake was done 
via a 3-day food record, a 
24 hour recall and FFQ. 
Photographic imaging 
was used to determine 
portions.  
GF breads had 1/3 less 
protein (P<0.001) and 
twice as much fat 
(P=0.001), primarily 
saturated. Pasta had 
similar nutrient profile 
as breads but also had 
more sodium and less 
fiber. Women had 
lower protein and 
higher fat intake. Men 
and women had lower 
fiber intake.  
Following a GF 
diet could impose 
nutritional 
deficiencies if 
using multiple 
gluten alternative 
products.  
Small sample 
size of products 
analyzed when 
divided into 
subgroups. 
There were 
significantly 
more women 
than men in this 
study, which 
could influence 
the fact that 
women had 
more prominent 
results when it 
came to 
intakes.   
Newnham et 
al., 2016, 
observational 
(cohort) 
To evaluate 
the effect of 
treatment of 
patients new 
CD with a 
GFD on 
mucosal 
healing, body 
composition, 
and Celiac 
serology 
followed for 5 
years.  
Adults ages 18 
years or older 
who were newly 
diagnosed with 
CD and referred 
to a single 
dietetic 
provider.  
All participants received 
dietary education from a 
dietitian. This 
information was 
refreshed after 6 weeks 
and again after 12 
months. At 1 year and 5 
year assessments, 
adherence to GFD was 
determined, peripheral 
blood was collected, body 
composition assessed, 
and endoscopy and 
biopsy were completed.  
Dietary compliance 
was good or excellent 
in all but one study 
participant. Mucosal 
remission increased 
with time. Fat mass 
increased significantly 
over the first year in 
those with normal/low 
BMI. Lean body mass 
improved at the 5 year 
check. Bone mass 
increased only in those 
with osteopenia or 
Adherence to a 
GFD showed 
improvements in 
intestinal healing 
and return of 
normal body 
compositions.  
Extremely high 
compliance rate 
to diet, which 
could be a 
source of bias. 
Objective 
adherence of 
diet was 
utilized instead 
of subjective.  
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osteoporosis after the 
first year.  
Reilly et al., 
2011, 
observational 
(cohort) 
To evaluate 
children with 
CD who are 
normal or 
overweight 
BMI for age at 
diagnosis and 
to determine 
changes that 
occur in their 
growth after 
following a 
GFD long-
term. 
Children with 
confirmed CD 
recruited at a 
clinic in the US 
between 2000 
and 2008.  
Data was obtained 
retrospectively through 
medical records. 
Compliance to GFD was 
determine via 
consultations with 
nutritionist and 
serological assays. 
Patients with normal 
assays within 2 years of 
diagnosis and who 
continued to have 
seronegativity were 
deemed adherent to the 
diet.  
Mean duration of 
follow up was 35.6 
months. 19% of 
patients had elevated 
BMI at diagnosis and 
74.5% had normal 
BMI. 75% of 
individuals with 
elevated BMI at 
diagnosis decreased 
their BMI significantly 
and normalizing in 
44% of the cases 
(P=0.01). Patients with 
a normal BMI at 
diagnosis increased 
their weight and 13% 
became overweight 
(P<0.01).  
Children with CD 
could experience 
beneficial effects of 
the GFD if they are 
obese or 
overweight.  
Data was 
obtained 
retrospectively.  
Abid et al., 
2011, 
observational 
(longitudinal) 
To observe the 
effects of a 
GFD in a 
group of 
children with 
confirmed 
T1DM and 
CD.  
Children 
recruited by a 
clinic in Ireland 
already 
presenting with 
T1DM and CD 
between 
November 2000 
and November 
2007.  
Subjects followed a GFD. 
Data was collected on 
them before starting the 
diet and again after 
following the diet for 12 
months. Data collected 
included GI symptoms, 
episodes of severe 
hypoglycemia, daily 
insulin requirements, 
height, weight, BMI, 
HbA1c, hemoglobin and 
persistence of 
autoantibodies.  
Ten out of 11 children 
showed improvement 
in GI symptoms. Six 
out of 8 patients no 
longer had severe 
hypoglycemic 
episodes. 9 children 
continued to test 
positive for 
autoantibodies. There 
was no significant 
change in height, 
weight, BMI or 
HbA1c before and 
after adherence to the 
The GFD did 
demonstrate some 
beneficial effects 
such as reducing GI 
symptoms and 
severe 
hypoglycemic 
episodes. Insulin 
increase on the 
GFD.  
There were no 
matched 
controls to the 
intervention 
groups. 
Additionally, 
researchers did 
not confirm 
subjects were 
adhering to the 
GFD 
religiously.  
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diet. The mean insulin 
requirement increased 
from 0.88 to 1.1 
units/kg/day (p < 
0.005). 
Primary Sources, Neutral Quality Rating 
Welander et 
a., 2014, 
observational 
(cohort) 
To determine 
if children 
have an 
increased risk 
of T1DM after 
suffering an 
infection at 
the time of 
gluten 
introduction.  
All children 
born in 
southeast 
Sweden between 
October 1997 
and October 
1999 who had 
parent consent. 
Data from 9,414 
children was 
used.  
Parents kept a diary of the 
date they stopped 
breastfeeding, the dates 
of introduction to gluten 
containing foods, and the 
dates of all infections 
during their child’s first 
year of life. The diary 
was turned in when child 
reached one year of age. 
Children were 13 years 
old at the end of the 
study.  
No association was 
found relating infant 
feeding practices to 
risk of T1DM. 
Infection at time of 
gluten introduction 
played no role in 
future risk of T1DM. 
The age at gluten 
introduction, 
breastfeeding duration 
or gluten introduction 
while breastfeeding 
did not determine 
future risk for T1DM.  
Gluten introduction 
at time of infection 
during the first year 
of life is not a 
major risk factor 
for later 
development of 
T1DM.  
Information 
was not 
collected for 
other 
confounding 
factors such as 
exposure to 
cow’s milk 
protein, 
maternal 
obesity, 
maternal 
gestational 
diabetes, and 
maternal 
dietary 
restrictions and 
intolerances.  
Virtanen et 
al., 2011, 
observational 
(cohort) 
To assess 
whether early 
introduction of 
cow’s milk, 
cereals, root 
vegetables and 
fruits 
increases the 
risk of 
expression of 
diabetes-
associated 
Newborn infants 
from Finland 
recruited from 
three hospitals 
all of which 
express the 
genotype for 
T1DM, making 
them high risk. 
Diabetes-associated 
autoantibodies were 
measured at 3 – 12 month 
intervals. Families kept 
record of age at 
introduction of new foods 
and answered a 
questionnaire regarding 
this information at each 
visit. The endpoint was 
repeated positive tests for 
islet cell antibodies, plus 
Introduction of root 
vegetables by 4 
months old was 
associated with an 
increased risk of beta-
cell autoimmunity. 
Introduction of cereals 
and egg were 
associated with the 
endpoint of the study 
but only for the first 3 
years of life.   
Early introduction 
of root vegetables 
by the age of 4 
months old is 
associated with an 
increased risk of 
beta-cell 
autoimmunity in 
kids with high 
genetic risk of 
T1DM.  
Only age at the 
introduction of 
new foods was 
included, not 
the amount of 
food that was 
consumed.  
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autoantibodies
.  
at least one other 
antibody and/or T1DM.  
Frederiksen 
et al., 2013, 
observational 
(cohort) 
To observe 
infant 
exposures, 
especially 
diet, and their 
association 
with 
development 
of T1DM.  
Genetically at-
risk children 
recruited from 
either a hospital 
or clinic in 
Denver, 
Colorado. Kids 
were placed into 
one of two 
groups. One 
group consisted 
of babies who 
were genetically 
tested for the 
HLA genotype. 
The other group 
were newborns 
to the age of 8 
years old with 
one first-degree 
relative with 
T1DM.  
Dietary intake data for 
infants was collected 
from mothers either over 
the phone or in in-person 
interviews every 3 
months until 15 months 
of age. Children 
completed clinic visits 
annually. Diabetes was 
diagnosed by a physician 
and was confirmed by 
polyuria, polydipsia and a 
glucose tolerance test.  
Early (<4 months of 
age) exposure to fruit 
and late (>/=6 months 
of age) exposure to 
rice/oat was associated 
with increased rates of 
T1DM. Hazard ratios 
of 2.23 and 2.88, 
respectively with 95% 
CI). Breastfeeding 
during wheat/barley 
introduction was 
found to protect 
against T1DM.  
Introduction of new 
foods between the 
ages of 4 and 5 
months appears to 
be safe. 
Breastfeeding 
appears to have 
protection effect 
against T1DM.  
An amount of 
each food at 
each 
introduction 
was not 
provided. 
Additionally, 
there was no 
information 
given about 
who recorded 
or interpreted 
nutrition intake, 
such as nurses 
doctors or 
dietitians.  
Digiacomo et 
al., 2013, 
observational 
(cohort) 
To estimate 
the prevalence 
of those 
following the 
GFD without 
CD diagnosis 
and determine 
their 
demographics 
and general 
health status.  
Adult 
participants 
from the 
NHANES 
survey from 
2009 – 2010.  
Participants responded to 
questionnaires about 
following a GFD. Lab 
results and body 
measurements were 
obtained.  
Weighted national 
average of those 
following GFD 
without CD in the 
United States was 
0.548% (about half of 
CD prevalence). 
Prevalence was higher 
in females than in 
males, which was not 
significant. 
Participants on a GFD 
GFD could have 
positive effect on 
weight status. 
National 
prevalence of 
following GFD was 
0.548%. 
Results could 
be biased as 
these were 
people who 
received an 
annual 
physical, so 
they could be 
more health 
conscious. 
Other factors 
such as 
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were more likely to be 
normal weight.  
physical 
activity were 
not considered. 
Adherence to 
GF diet was 
self-reported in 
a yes/no 
question.  
Kim et al., 
2017, 
observational 
(cohort) 
To investigate 
the effect of 
the GFD on 
obesity, 
metabolic 
syndrome and 
CVD risk in 
the general 
healthy 
population. 
Participants of 
the National 
health and 
Nutrition 
Examination 
Survey 
(NHANES) in 
the United 
States. Years 
used were 2009 
– 2010, 2011 – 
2012, and 2013 
– 2014. Subjects 
were 6 years old 
or older and did 
not have CD. 
Dietary adherence was 
self-reported by 
answering question, “Are 
you on a GFD?” Blood 
pressure and 
anthropometrics were 
obtained. Metabolic 
syndrome was defined as 
having three of the 
following: abdominal 
obesity, high 
triglycerides, low HDL, 
high blood pressure, and 
high fasting blood 
glucose. 
Weighted prevalence 
of GFD followers 
without CD was 1.3% 
or 3.2 million 
Americans. Those 
following a GFD were 
more likely to be of 
normal weight. 
GFD may be 
beneficial in weight 
management, but 
does not decrease 
your risk of 
metabolic 
syndrome or CVD. 
Potential of 
recall bias as 
adherence to 
GFD was 
patient-
reported. The 
degree of 
adherence and 
duration of 
GFD was not 
assessed. The 
number of GFD 
followers for 
analysis was 
small. 
Martin et al., 
2013, 
observational 
(case-control) 
To evaluate 
the nutritional 
value of the 
GFD and 
compare it to 
recommendati
ons and intake 
of general 
population. 
Additional 
aim was to 
determine 
Members of the 
German Celiac 
Society ages 8 – 
17 years old. 
Members of this 
group 
voluntarily 
joined.  
Participants completed a 
7-day food diary which 
was analyzed by using 
DGE-PC Professional. 
Nutrient intake of CD 
patients was compared to 
general German 
population.  
CD men did not have 
significant difference 
in energy intake 
compared to general 
population. Fiber 
intake was 
significantly lower in 
males (did not meet 
daily 
recommendation) than 
females. Females 
showed higher fat and 
CD patients in 
Germany did have 
inadequate nutrient 
intakes on a GFD.  
Relatively 
small sample 
size. Selection 
process of 
study sample 
hinders ability 
to generalize 
results to entire 
CD population. 
There were no 
lab values 
collected to 
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portion of diet 
using special 
gluten-free 
products.   
lower carbohydrate 
intake. Both males and 
females had lower B1, 
B2, B6, folic acid, 
magnesium and iron 
intake compared to 
healthy population.  
determine 
serum nutrient 
levels.  
Wild et al., 
2010, 
observational 
(case-control) 
To determine 
the nutrition 
composition 
of a GFD and 
compare it 
with a non-
GFD in non-
CD 
populations. 
Adult CD 
patients who had 
followed GFD 
for at least 6 
months. Patients 
were recruited 
by dietitian at 
GI clinic. Non-
celiac 
population was 
from NDNS 
survey.  
Adherence to GFD was 
self-reported and under 
review of dietitian. 
Dietary intake was taken 
by EPIC diary utilizing 
food pictures for portion 
sizes. Diaries analyzed by 
Microdiet version 2.52. 
Reference data to general 
population was collected 
via NDNS survey. 
Information on this 
survey was collected 
from a validated FFQ.  
Females on GFD had 
lower intake of 
magnesium, iron, zinc, 
manganese, selenium 
and folate. Males had 
low intakes of 
magnesium and 
selenium.  
Subjects following 
a GFD did show 
nutritional 
inadequacies in 
their diet. 
Avoidance of 
gluten should not 
be sole focus on 
following a GFD.  
Relatively 
small sample 
size. Younger 
population was 
not well 
represented in 
comparator 
population.  
 
